Latest Breaking News On - Kyeongje news - Page 1 : comparemela.com

The COVID-19 drug under trial As per The Korea Herald, this phase 3 is the final step in the human tests of the medicine that was named Regkirona or CT-P59. It was mentioned that the trials are being done in 13 nations that include the U.S., South Korea, Romania, and Spain. Based on the report, the said drug has been approved in Korea for emergency use and was issued an authorization in February. It was then used to treat patients with mild symptoms in adults and those belonging to high-risk groups. Celltrion shared that they did not find any unusual reaction from a group of patients who received the drug.

Inch on gwangyoksiSouth koreaSeo jung jinSeo joon serkSeo jin seokJin seokCelltrion holdingsCelltrion healthcare holdingsKorea heraldKyeongje newsCelltrion healthcareReal time economy newsOrex newsIgital currency newsConomy researchConomy commentaries